Correlation Between Dogwood Therapeutics, and Ensysce Biosciences

Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Ensysce Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Ensysce Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dogwood Therapeutics, and Ensysce Biosciences, you can compare the effects of market volatilities on Dogwood Therapeutics, and Ensysce Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Ensysce Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Ensysce Biosciences.

Diversification Opportunities for Dogwood Therapeutics, and Ensysce Biosciences

-0.24

Correlation Coefficient

Dogwood Therapeutics,  Ensysce Biosciences

Very good diversification

The 3 months correlation between Dogwood and Ensysce is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Ensysce Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ensysce Biosciences and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Ensysce Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ensysce Biosciences has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Ensysce Biosciences go up and down completely randomly.

Pair Corralation between Dogwood Therapeutics, and Ensysce Biosciences

Given the investment horizon of 90 days Dogwood Therapeutics, is expected to generate 9.46 times more return on investment than Ensysce Biosciences. However, Dogwood Therapeutics, is 9.46 times more volatile than Ensysce Biosciences. It trades about 0.12 of its potential returns per unit of risk. Ensysce Biosciences is currently generating about -0.23 per unit of risk. If you would invest  272.00  in Dogwood Therapeutics, on December 21, 2024 and sell it today you would earn a total of  401.00  from holding Dogwood Therapeutics, or generate 147.43% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Dogwood Therapeutics,  vs.  Ensysce Biosciences

Dogwood Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Dogwood Therapeutics, are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dogwood Therapeutics, showed solid returns over the last few months and may actually be approaching a breakup point.

Ensysce Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ensysce Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Dogwood Therapeutics, and Ensysce Biosciences

The main advantage of trading using opposite Dogwood Therapeutics, and Ensysce Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Ensysce Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ensysce Biosciences will offset losses from the drop in Ensysce Biosciences' long position.

The idea behind Dogwood Therapeutics, and Ensysce Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.